Last reviewed · How we verify
NCT05827224
Air Optix Daily Wear Contact Lenses
trial testing Lotrafilcon B spherical soft contact lenses in Refractive Errors in 312 participants. Completed in 17 July 2024.
17 July 2024
Quick facts
| Lead sponsor | Alcon Research |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 312 |
| Start date | 2 August 2023 |
| Primary completion | 17 July 2024 |
| Estimated completion | 17 July 2024 |
| Sites | 5 locations across United States |
Drugs / interventions tested
- Lotrafilcon B spherical soft contact lenses
- Lotrafilcon B spherical soft contact lenses with comfort additive
- Lotrafilcon B toric soft contact lenses with comfort additive
- Comfilcon A spherical soft contact lenses
- Comfilcon A toric soft contact lenses
Conditions studied
- Refractive Errors — all drugs for Refractive Errors →
Sponsor
Alcon Research — full company profile →
Who can join
18 and older, any sex, with Refractive Errors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix Aqua, Air Optix plus HydraGlyde Sphere, and Air Optix plus HydraGlyde Toric soft contact lenses in a real-world setting when worn as daily wear.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05827224
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lotrafilcon B spherical soft contact lenses
Trials testing the same drug.
- NCT05886881 — Air Optix Extended Wear Contact Lenses · completed
Other recruiting trials for Refractive Errors
Currently open trials in the same condition.
- NCT07460557 — Morphological Characteristics of the Maxillomandibular Region in a 3D Representation and the Refractive Status of the Ey · recruiting
- NCT06913491 — Efficacy of PEEK Acuity Versus ETDRS Chart for Assessment of Visual Acuity and Refractive Error · active not recruiting
- NCT07001124 — Comparative Efficacy of Duochrome Test Verse +1 Blur Test in Detecting Refracting Error Across Different Ages · NA · active not recruiting
- NCT06668246 — Performance of Refractometers With Self-adjusting Lenses Compared to Cycloplegia in Children (REFRALENS) · active not recruiting
- NCT05458323 — Cognitive Level Enhancement Through Vision Exams and Refraction · NA · recruiting
Other Alcon Research trials
Trials by the same sponsor.
- NCT06884202 — Evaluation of Delefilcon A Contact Lenses · NA · completed
- NCT06784063 — Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs) · NA · completed
- NCT06571656 — Evaluation of the Safety and Tolerability of Ocular Lubricants · NA · terminated
- NCT06660290 — A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes · Phase 3 · completed
- NCT06483113 — DAILIES TOTAL1® Soft Contact Lenses - Post-Market Clinical Follow-up Study · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05827224 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Alcon Research
- Last refreshed: 15 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05827224.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing